Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen
Ligand Pharmaceuticals Incorporated announces the signing of an agreement whereby Ligand will acquire the core assets of Icagen, Inc.’s North Carolina operations, including partnered…
Read More...
Read More...
